Bayer | BAYN - Ordinary Share Capital


Bayer reported EUR982.42M in Ordinary Share Capital for its fiscal quarter ending in June of 2026.





Ordinary Share Capital Change Date
Air Liquide EUR 577.57M 2.6B Dec/2025
Akzo Nobel EUR 171.41M 100K Jun/2026
Alcon AG USD 487.4M 0 Jun/2026
Amarin USD 20.81M 13K Dec/2025
Arkema EUR 75.61M 56K Jun/2026
AstraZeneca USD 1.55B 44K Jun/2026
BASF EUR 884.32M 8.2M Jun/2026
Bayer EUR 982.42M 0 Jun/2026
Beiersdorf EUR 218.92M 1.29M Dec/2025
Corteva USD 667.02M 3.03M Jun/2026
Covestro EUR 207.64M 18.9M Dec/2025
Essilor EUR 463.19M 144.06K Jun/2026
Fresenius EUR 563.24M 0 Jun/2026
Fresenius Medical Care EUR 266.11M 3.98M Jun/2026
Genmab DKK 61.44M 181K Jun/2026
Givaudan CHF 9.23M 0 Dec/2025
GlaxoSmithKline GBP 4.08B 20.6M Jun/2026
GRIFOLS EUR 680.58M 6K Jun/2026
Henkel EUR 404.85M 1.94M Jun/2026
Hikma Pharmaceutical USD 221.89M 181.89M Dec/2025
Johnson Matthey GBP 168.06M 0 Jun/2026
Linde USD 462.6M 1.08M Mar/2026
Lonza CHF 68.64M 0 Dec/2025
Merck EUR 434.78M 0 Jun/2026
Novartis USD 1.9B 7.38M Jun/2026
Nutrien USD 480.76M 1.2M Mar/2026
Philips EUR 952.02M 729K Mar/2026
PPG Industries USD 222.3M 600K Jun/2026
Roche Holding CHF 796.77M 1.15M Jun/2026
Sanofi EUR 1.21B 8.25M Mar/2026
SAP EUR 1.17B 1.06M Mar/2026
Solvay EUR 104.62M 145K Jun/2026
UCB EUR 190.36M 365.15K Dec/2025
Umicore EUR 240.56M 1.14B Dec/2025
Vinci EUR 554.14M 1.82M Jun/2026